The exosomal delivery of TGF-β contributes to the activation of TGF-β signaling under pathological conditions such as tumor and hypoxia, contributing to EMT and myofibroblast differentiation (Ahuja et al., 2020; Chowdhury et al., 2015). This evidence concerns the gene TGFB1 and neoplasm.